The following is a reconciliation of basic and diluted net income per share from continuing operations for the respective periods: | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | In millions, except per share amounts | 2016 | | 2015 | | 2016 | | 2015 | Numerator for earnings per share calculations: | | | | | | | | Income from continuing operations | $ | 1,542 |
| | $ | 1,237 |
| | $ | 3,613 |
| | $ | 3,730 |
| Income allocated to participating securities | (7 | ) | | (6 | ) | | (18 | ) | | (18 | ) | Net income attributable to noncontrolling interest | (1 | ) | | (1 | ) | | (2 | ) | | (1 | ) | Income from continuing operations attributable to CVS Health | $ | 1,534 |
| | $ | 1,230 |
| | $ | 3,593 |
| | $ | 3,711 |
| | | | | | | | | Denominators for earnings per share calculations: | |
| | |
| | |
| | | Weighted average shares, basic | 1,068 |
| | 1,114 |
| | 1,076 |
| | 1,122 |
| Effect of dilutive securities | 5 |
| | 7 |
| | 6 |
| | 8 |
| Weighted average shares, diluted | 1,073 |
| | 1,121 |
| | 1,082 |
| | 1,130 |
| | | | | | | | | Earnings per share from continuing operations: | |
| | |
| | |
| | |
| Basic | $ | 1.44 |
| | $ | 1.10 |
| | $ | 3.34 |
| | $ | 3.31 |
| Diluted | $ | 1.43 |
| | $ | 1.10 |
| | $ | 3.32 |
| | $ | 3.28 |
|
|